» Articles » PMID: 39728015

Delayed Diagnosis of Disseminated Invasive Aspergillosis with Purulent Myocarditis in an Immunocompromised Host

Overview
Journal Infect Dis Rep
Publisher MDPI
Date 2024 Dec 27
PMID 39728015
Authors
Affiliations
Soon will be listed here.
Abstract

Invasive aspergillosis (IA) is an opportunistic fungal infection that typically occurs in the immunocompromised host and is associated with severe morbidity and mortality. Myocardial abscess formation is seldomly described. We present a case of IA with purulent myocarditis. The patient was on long-term high-dose corticosteroid and mycophenolate mofetil therapy for severe lupus nephritis. After multiple visits to his general practitioner and nephrologist for general malaise, he was admitted to our hospital with visual complaints. Within several days, he developed atrial fibrillation, respiratory insufficiency, and, finally, a decreased level of consciousness. After admission to the intensive care unit, the broncho alveolar lavage (BAL) fluid galactomannan (GM) index was normal, but the serum GM index was severely elevated. Despite initiation of antifungal therapy, the patient passed away shortly thereafter. Autopsy revealed massive intracranial hemorrhage and disseminated IA affecting the lungs, brain, and myocardium, with macroscopic myocardial abscess formation. This classic case of diagnostic uncertainty illustrates how invasive fungal infections can progress to disseminated disease while showing nonspecific symptoms only. It emphasizes the importance of vigilance for opportunistic fungal infections in a growing category of immunocompromised patients. Clinicians should have a low threshold of suspicion for fungal infections in patients on combination immunosuppressive medication, such as high-dose corticosteroid therapy in combination with T-cell inhibitors like MMF.

References
1.
Xie L, Gebre W, Szabo K, Lin J . Cardiac aspergillosis in patients with acquired immunodeficiency syndrome: a case report and review of the literature. Arch Pathol Lab Med. 2005; 129(4):511-5. DOI: 10.5858/2005-129-511-CAIPWA. View

2.
Burke B, STORRING F, Parry T . Disseminated aspergillosis. Thorax. 1970; 25(6):702-7. PMC: 472212. DOI: 10.1136/thx.25.6.702. View

3.
Boch T, Buchheidt D, Spiess B, Miethke T, Hofmann W, Reinwald M . Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis. Mycoses. 2015; 59(2):80-5. DOI: 10.1111/myc.12434. View

4.
Ishino Y, Fukasawa H, Kitamoto S, Nakagami D, Kaneko M, Yasuda H . A survival case of visceral disseminated varicella zoster virus infection in a patient with systemic lupus erythematosus. BMC Nephrol. 2023; 24(1):164. PMC: 10251651. DOI: 10.1186/s12882-023-03223-0. View

5.
Cox J, Di Dio F, Pizzolato G, Lerch R, Pochon N . Aspergillus endocarditis and myocarditis in a patient with the acquired immunodeficiency syndrome (AIDS). A review of the literature. Virchows Arch A Pathol Anat Histopathol. 1990; 417(3):255-9. DOI: 10.1007/BF01600142. View